Flu :: Cognis Targets Cold, Flu Season with Arsenal of Immunity-Enhancing Ingredients

A compromised immune system makes people more prone to contracting a cold or flu, and Cognis is helping companies meet the growing demand worldwide for immunity boosting dietary supplements and functional foods. Colds and flu are the most frequent infections across all age groups. Each year, Americans suffer from one billion colds, 100,000 are hospitalized and about 36,000 die from the flu and its complications. Immune health is also a global concern with frequent colds and flu ranked as one of the top three health problems by consumers in China, India and Latin America.

Nutrition :: Cognis to launch Omevital, omega-3 fatty acids at HiE

Cognis will unveil its new range of high quality omega-3 fish oil products at this year?s Health Ingredients Europe event in Frankfurt. Under the brand name Omevital?, and available in ethyl ester and triglyceride forms, the new range of marine-origin oils delivers products of outstanding quality and purity, ultra-refined through state-of-the-art manufacturing processes, in accordance with Pharma GMP standards.

Health :: Investigation of the physical and psychological health of UK Armed Forces

The King’s Centre for Military Health Research (KCMHR) has received further funding from the UK Ministry of Defence to continue its research into the health and well-being of military personnel, many of whom have served in Iraq. The research, which began in 2003 as a prospective investigation of the physical and psychological health of over 12,000 UK service personnel serving in Iraq, will be monitoring service personnel more widely, including those deployed to Afghanistan.

Alzheimer’s Disease :: Diagnosis before onset of Alzheimer’s disease

Proteins found in the blood can indicate an increased risk of Alzheimer’s disease, according to groundbreaking new research published today (30 October) in the journal Brain. It is the first time markers for the development of Alzheimer’s have been identified in blood. The findings take researchers a step closer to knowing whether a blood test can be used to diagnose and measure progression of the Alzheimer’s disease.

Tuberculosis :: Testing and diagnosis process not adequate

Most of the nine million people who fall ill with tuberculosis each year lack access to adequate testing and diagnosis, complicating efforts to stop its spread, the World Health Organisation (WHO) said. The United Nations agency said big investments were needed to develop diagnostics in low and middle income countries, where three-quarters of screenings take place for the respiratory system disease which claims 1.7 million lives a year.

Health :: Glivec, imatinib approved for five rare life threatening disorders

In another important milestone, Glivec? (imatinib) has received US regulatory approval to help patients with five distinct and potentially life-threatening disorders, representing the first time that a regulatory authority has ever simultaneously approved one targeted medicine for so many disorders. With today’s decision, and in only five years, Glivec has now been approved in the US for seven diseases, including two solid tumors and five blood disorders with molecular targets known to be inhibited by the drug.

Success :: Blueprint for Success – Defining Your Goals

Goal means what your aim to reach in the future. In your life establishing goals has a positive impact. A goal is a specific, assessable result that you want to generate at a determinable time in the future. But if what you hope to achieve in life is based on your expectations, rather than on working to reach established goals. Your goals are the stepping-stones toward the understanding of your dreams, the second key element in the blueprint of your life.

Influenza :: Novartis cell culture-derived influenza vaccine well tolerated and efficacious

Novartis (NYSE: NVS) announced today results of pivotal Phase III clinical trial data for its innovative cell culture-derived influenza vaccine demonstrating that it is highly capable of producing an immune response (“immunogenic”), one at least as strong as the traditional egg-derived influenza vaccine Aggripal? for each of the three influenza strains studied.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack